1. Dieri RA, Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, et al. The Thrombogram in Rare Inherited Coagulation Disorders: Its Relation to Clinical Bleeding [Internet]. Thrombosis and Haemostasis. 2002. page 576–82. Available from: http://dx.doi.org/10.1055/s-0037-1613258
2. Dieri RA, Al Dieri R, Wagenvoord R, Van Dedem GWK, Beguin S, Hemker HC. The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif-the C-domain [Internet]. Journal of Thrombosis and Haemostasis. 2003. page 907–14. Available from: http://dx.doi.org/10.1046/j.1538-7836.2003.00211.x
3. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002;32:249–53.
4. Eriksson U, Mattsson C, Wolzt M, Frison L, Fager G, Gustafsson D, et al. Inhibition of Thrombin Generation by the Oral Direct Thrombin Inhibitor Ximelagatran in Shed Blood from Healthy Male Subjects [Internet]. Thrombosis and Haemostasis. 2002. page 300–5. Available from: http://dx.doi.org/10.1055/s-0037-1612989
5. Hc H. Béguin s. Phenotyping the clotting system. Thromb Haemost. 2000;84:747–51.
6. Chelle P, Montmartin A, Piot M, Ardillon L, Wibaut B, Frotscher B, et al. Prediction of individual factor VIII or IX level for the correction of thrombin generation in haemophilic patients. Haemophilia. 2018;24:995–1001.
7. Dielis AJH, Spronk HMH, van Oerle R, Hamulyak K, Prins MH, ten Cate H, et al. Thrombin generation in patients after acute deep-vein thrombosis [Internet]. Thrombosis and Haemostasis. 2008. page 240–5. Available from: http://dx.doi.org/10.1160/th08-02-0099
8. Marchetti M, Castoldi E, Spronk HMH, van Oerle R, Balducci D, Barbui T, et al. Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera. Blood. 2008;112:4061–8.
9. Loeffen R, van Oerle R, Leers MPG, Kragten JA, Crijns H, Spronk HMH, et al. Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events [Internet]. PLOS ONE. 2016. page e0158355. Available from: http://dx.doi.org/10.1371/journal.pone.0158355
10. Smid M, Dielis AWJH, Winkens M, Spronk HMH, van Oerle R, Hamulyák K, et al. Thrombin generation in patients with a first acute myocardial infarction. J Thromb Haemost. 2011;9:450–6.
11. Smid M, Dielis AWJH, Spronk HMH, Rumley A, van Oerle R, Woodward M, et al. Thrombin generation in the Glasgow Myocardial Infarction Study. PLoS One. 2013;8:e66977.
12. Carcaillon L, Alhenc-Gelas M, Bejot Y, Spaft C, Ducimetière P, Ritchie K, et al. Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-City cohort study. Arterioscler Thromb Vasc Biol. 2011;31:1445–51.
13. Panova-Noeva M, Eggebrecht L, Prochaska JH, Wild PS. Potential of Multidimensional, Large-scale Biodatabases to Elucidate Coagulation and Platelet Pathways as an Approach towards Precision Medicine in Thrombotic Disease. Hamostaseologie. 2019;39:152–63.
14. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AWA, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003;348:1435–41.
15. Lowe GDO. Common risk factors for both arterial and venous thrombosis. Br J Haematol. 2008;140:488–95.
16. Schnabel RB, Wilde S, Wild PS, Munzel T, Blankenberg S. Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int. 2012;109:293–9.
17. Wild PS, Sinning CR, Roth A, Wilde S, Schnabel RB, Lubos E, et al. Distribution and categorization of left ventricular measurements in the general population: results from the population-based Gutenberg Heart Study. Circ Cardiovasc Imaging. 2010;3:604–13.
18. Wild PS, Zeller T, Beutel M, Blettner M, Dugi KA, Lackner KJ, et al. [The Gutenberg Health Study]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55:824–9.
19. Loeffen R, Kleinegris M-CF, S T B, Pluijmen PHM, Fens D, van OERLE R, et al. Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method [Internet]. Journal of Thrombosis and Haemostasis. 2012. page 2544–54. Available from: http://dx.doi.org/10.1111/jth.12012
20. van Paridon PCS, Panova-Noeva M, van Oerle R, Schultz A, Hermanns IM, Prochaska JH, et al. Thrombin generation in cardiovascular disease and mortality - results from the Gutenberg Health Study. Haematologica [Internet]. 2019; Available from: http://dx.doi.org/10.3324/haematol.2019.221655
21. Dielis AWJH, A W J, Castoldi E, Spronk HMH, Van Oerle R, Hamulyák K, et al. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population [Internet]. Journal of Thrombosis and Haemostasis. 2007. page 125–31. Available from: http://dx.doi.org/10.1111/j.1538-7836.2007.02824.x
22. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3:1894–904.
23. Spronk HMH, Govers-Riemslag JWP, ten Cate H. The blood coagulation system as a molecular machine. Bioessays. 2003;25:1220–8.
24. Hermanns MI, Grossmann V, Spronk HMH, Schulz A, Jünger C, Laubert-Reh D, et al. Distribution, genetic and cardiovascular determinants of FVIII:c - Data from the population-based Gutenberg Health Study. Int J Cardiol. 2015;187:166–74.
25. Woodward M, Lowe GD, Rumley A, Tunstall-Pedoe H, Philippou H, Lane DA, et al. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 1997;97:785–97.
26. Lowe G, Rumley A. The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us? Thromb Haemost. 2014;112:860–7.
27. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698–703.
28. Kraaijenhagen RA, in’t Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost. 2000;83:5–9.
29. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood. 2000;95:3678–82.
30. Ten Cate H. Thrombin generation in clinical conditions. Thromb Res. 2012;129:367–70.